ABEONA THERAPEUTICS INC. Accounts Payable
ABEONA THERAPEUTICS INC. (ABEO) had Accounts Payable of $2.99 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-13
- 2026-06-30: Accounts Payable, Current $2.99M.
- 2026-03-31: Accounts Payable, Current $4.07M.
- 2025-12-31: Accounts Payable, Current $7.89M.
- 2025-09-30: Accounts Payable, Current $5.93M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.99M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $4.07M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $7.89M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $5.93M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $7.34M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $5.02M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $3.44M 10-K · filed 2026-03-17 | |
| 2024-09-30 | $2.79M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $3.10M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $3.36M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $1.86M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $2.59M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $3.48M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $2.86M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.81M 10-K · filed 2024-03-18 | |
| 2022-09-30 | $1.75M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.74M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.60M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $4.33M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $1.86M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $1.47M 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $2.48M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $4.70M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $1.26M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $1.98M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $1.76M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $3.76M 10-K · filed 2021-03-24 | |
| 2019-09-30 | $2.71M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $7.16M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $4.19M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $6.12M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $10.33M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $5.78M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $5.91M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $1.88M 10-K · filed 2019-03-18 | $2.39M 10-K · filed 2018-03-16 |
| 2017-09-30 | $2.04M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $3.62M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $1.46M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $3.69M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $1.91M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $2.10M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $1.04M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $875.00K 10-K · filed 2017-03-30 | |
| 2015-09-30 | $968.00K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $1.32M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $638.00K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $1.90M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $1.63M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $1.34M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $1.07M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $863.00K 10-K · filed 2015-03-31 | |
| 2013-09-30 | $706.00K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $1.30M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $2.38M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $2.04M 10-K · filed 2014-03-26 | |
| 2012-09-30 | $2.35M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $2.41M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $1.88M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $1.71M 10-K · filed 2013-03-20 | |
| 2011-09-30 | $1.63M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $2.95M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $2.98M 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |